RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers

被引：0

作者：

Emma Nolan

François Vaillant

Daniel Branstetter

Bhupinder Pal

Göknur Giner

Lachlan Whitehead

Sheau W Lok

Gregory B Mann

Kathy Rohrbach

Li-Ya Huang

Rosalia Soriano

Gordon K Smyth

William C Dougall

Jane E Visvader

Geoffrey J Lindeman

机构：

[1] Walter and Eliza Hall Institute of Medical Research (WEHI),ACRF Stem Cells and Cancer Division

[2] University of Melbourne,Department of Medical Biology

[3] Amgen Inc.,Department of Pathology

[4] Walter and Eliza Hall Institute of Medical Research,Bioinformatics Division

[5] Imaging Laboratory,Systems Biology and Personalized Medicine Division

[6] Walter and Eliza Hall Institute of Medical Research,Department of Medical Oncology

[7] Familial Cancer Centre,Department of Surgery

[8] Royal Melbourne Hospital,Department of Mathematics and Statistics

[9] Royal Melbourne Hospital,Department of Medicine

[10] The Breast Service,undefined

[11] Royal Melbourne Hospital and Royal Women's Hospital,undefined

[12] University of Melbourne,undefined

[13] University of Melbourne,undefined

[14] Therapeutic Innovation Unit,undefined

[15] Amgen Inc.,undefined

[16] University of Melbourne,undefined

[17] Familial Cancer Centre,undefined

[18] Victorian Comprehensive Cancer Centre,undefined

[19] Present addresses: Cynosure Clinical Research LLC,undefined

[20] North Bend,undefined

[21] Washington,undefined

[22] USA (D.B.); Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute,undefined

[23] Herston,undefined

[24] Queensland,undefined

[25] Australia (W.C.D.).,undefined

来源：

Nature Medicine | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A new study by Jane Visvader, Geoff Lindeman and colleagues reports on the potential role of RANK signaling in pre-neoplastic breast tissue from BRCA1-mutation carriers and in a mouse model of Brca1-deficient mammary cancer, suggesting that targeting RANK could be explored as an approach to prevent growth of tumors harboring mutated BRCA1.

引用

页码：933 / 939

页数：6

共 50 条

[31] Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation related breast cancere
Jones, LP
Li, M
Halama, ED
Ma, YX
Lubet, R
Grubbs, C
Deng, C
Rosen, E
Furth, PA
Lombardi, CCC
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S10 - S10
[32] BRCA1 as Target for Breast Cancer Prevention and Therapy
Romagnolo, Alberto P. G.
Romagnolo, Donato F.
Selmin, Ornella I.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (01) : 4 - 14
[33] Breast cancer in BRCA mutation carriers: medical treatment
Milani, Andrea
Geuna, Elena
Zucchini, Giorgia
Aversa, Caterina
Martinello, Rossella
Montemurro, Filippo
MINERVA GINECOLOGICA, 2016, 68 (05): : 557 - 565
[34] Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers
Gangi, Alexandra
Cass, Ilana
Paik, Daniel
Barmparas, Galinos
Karlan, Beth
Dang, Catherine
Li, Andrew
Walsh, Christine
Rimel, Bobbie J.
Amersi, Farin F.
JAMA SURGERY, 2014, 149 (12) : 1306 - 1313
[35] Costs of breast cancer surveillance in BRCA mutation carriers
Kamm, Y. J. L.
Boetes, C.
Adang, E. M. M.
Bult, P.
Bonenkamp, H. J.
Hoogerbrugge, N.
EJC SUPPLEMENTS, 2008, 6 (07): : 94 - 95
[36] Breast cancer after ovarian cancer in BRCA mutation carriers
Nanez, A.
Powell, C. B.
Garcia, C.
GYNECOLOGIC ONCOLOGY, 2020, 159 : 256 - 256
[37] Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
Kelly Metcalfe
Henry T. Lynch
Parviz Ghadirian
Nadine Tung
Charmaine Kim-Sing
Olufunmilayo I. Olopade
Susan Domchek
Andrea Eisen
William D. Foulkes
Barry Rosen
Danny Vesprini
Ping Sun
Steven A. Narod
Breast Cancer Research and Treatment, 2011, 127 : 287 - 296
[38] Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos
Jan Lubinski
Leonardo Salmena
Henry T Lynch
Charmaine Kim-Sing
William D Foulkes
Parviz Ghadirian
Susan L Neuhausen
Rochelle Demsky
Nadine Tung
Peter Ainsworth
Leigha Senter
Andrea Eisen
Charis Eng
Christian Singer
Ophira Ginsburg
Joanne Blum
Tomasz Huzarski
Aletta Poll
Ping Sun
Steven A Narod
Breast Cancer Research, 14
[39] Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
M Ahmed
F Lalloo
A Howell
DG Evans
Breast Cancer Research, 12
[40] Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer
Kuschel, B
Lux, MP
Goecke, TO
Beckmann, MW
EUROPEAN JOURNAL OF CANCER PREVENTION, 2000, 9 (03) : 139 - 150

← 1 2 3 4 5 →